Cite
MLA Citation
Kunio Sugahara et al.. “Amiselimod, a novel sphingosine 1‐phosphate receptor‐1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk.” British journal of pharmacology, vol. 174, n.d., pp. 15–27. http://access.bl.uk/ark:/81055/vdc_100039522682.0x00005d